The DMRT3 Knockout HAP1 Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout population targeting DMRT3. This loss-of-function model enables investigation of the DMRT3 transcription factor??s role in gene regulation. The polyclonal format provides a diverse allelic pool, minimizing clonal selection artifacts. The knockout is generated via targeted gene disruption, offering a controlled system for studying DMRT3 ablation in near-haploid human cells.
HAP1 is a fibroblast-like, adherent cell line derived from chronic myeloid leukemia with a near-haploid karyotype. This simplified genome accelerates genetic analysis and functional screening, as single-copy gene disruption efficiently produces null phenotypes. Widely used in signal transduction, cancer biology, and drug discovery, HAP1 provides a clean platform for gene function studies.
DMRT3 encodes a doublesex-related transcription factor critical for neuronal subtype specification and locomotor circuit formation, as well as testicular development. It functions downstream of retinoic acid, BMP4, and Notch signaling, directly regulating targets such as Lhx1 and Lhx3. DMRT3 interacts with other DMRT family proteins and NR5A1 to orchestrate transcriptional programs. Retinoic acid receptors and BMP4 activate DMRT3 expression, which then promotes neuronal specification genes. This knockout model allows dissection of these regulatory mechanisms in vitro.
In the HAP1 background, DMRT3 knockout offers an advanced tool for transcriptional network analysis, leveraging near-haploidy to reduce redundancy and enhance screening clarity. The model is suited for genome-wide CRISPR screens to identify DMRT3 synthetic lethal partners or pathway modulators. Despite HAP1??s non-neuronal origin, DMRT3??s roles in retinoic acid, BMP, and Wnt pathways permit interrogation of conserved mechanisms. Polyclonality ensures phenotypic robustness, avoiding clonal biases in mechanistic studies.
Applications include ChIP-qPCR for target binding, luciferase reporter assays for transcriptional activity, western blotting and RT-qPCR for effector quantification, and immunofluorescence for neuronal marker detection. Flow cytometry monitors surface protein changes, while high-throughput screens exploit the polyclonal pool for hit discovery. These cells thus serve as a versatile resource for genetic screening and differentiation studies. For further details, please contact Ascent Research.
